Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of CT radiomic features robust to acquisition and segmentation variations for improved prediction of radiotherapy-treated lung cancer patient recurrence.
Louis T, Lucia F, Cousin F, Mievis C, Jansen N, Duysinx B, Le Pennec R, Visvikis D, Nebbache M, Rehn M, Hamya M, Geier M, Salaun PY, Schick U, Hatt M, Coucke P, Lovinfosse P, Hustinx R. Louis T, et al. Sci Rep. 2024 Apr 19;14(1):9028. doi: 10.1038/s41598-024-58551-4. Sci Rep. 2024. PMID: 38641673 Free PMC article.
Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience.
Lucia F, Mievis C, Jansen N, Duysinx B, Cousin F, Louis T, Baiwir M, Ernst C, Wonner M, Hustinx R, Lovinfosse P, Coucke P. Lucia F, et al. Among authors: louis t. Clin Transl Radiat Oncol. 2024 Jan 3;45:100720. doi: 10.1016/j.ctro.2023.100720. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2024. PMID: 38288310 Free PMC article.
Multicentric development and evaluation of [18F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy.
Lucia F, Louis T, Cousin F, Bourbonne V, Visvikis D, Mievis C, Jansen N, Duysinx B, Le Pennec R, Nebbache M, Rehn M, Hamya M, Geier M, Salaun PY, Schick U, Hatt M, Coucke P, Hustinx R, Lovinfosse P. Lucia F, et al. Among authors: louis t. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1097-1108. doi: 10.1007/s00259-023-06510-y. Epub 2023 Nov 21. Eur J Nucl Med Mol Imaging. 2024. PMID: 37987783
Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Cousin F, Louis T, Dheur S, Aboubakar F, Ghaye B, Occhipinti M, Vos W, Bottari F, Paulus A, Sibille A, Vaillant F, Duysinx B, Guiot J, Hustinx R. Cousin F, et al. Among authors: louis t. Cancers (Basel). 2023 Mar 25;15(7):1968. doi: 10.3390/cancers15071968. Cancers (Basel). 2023. PMID: 37046629 Free PMC article.
316 results